Ignite Creation Date:
2024-05-06 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06000033
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-21
First Post:
2023-08-14
Brief Title:
Study of Disitamab Vedotin and Anlotinib in Patients With HR-Negative HER2-Low-Expressing Metastatic Breast Cancer
Sponsor:
Qilu Hospital of Shandong University
Organization:
Qilu Hospital of Shandong University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-14
First Submit QC Date:
August 14 2023
Study First Post Date:
2023-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-14
Last Update Post Date:
2023-08-21
Last Update Post Date Type:
ACTUAL